Insider Transactions for APPLIED GENETIC TECHNOLOGIES CORP (AGTC)

Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Potter Stephen W VP and Chief Business Officer Aug 15, 2020 Option Exercise $5.77 5,723 33,022 34,677 Aug 18, 2020, 06:22 PM
Shearman Mark S Chief Scientific Officer Aug 15, 2020 Option Exercise $5.77 5,723 33,022 33,277 Aug 18, 2020, 06:15 PM
Krol Patrick Johan Hendrik 10% Owner Dec 26, 2019 Sale $5.24 81,162 425,289 1,780,762 Dec 30, 2019, 04:33 PM
Krol Patrick Johan Hendrik 10% Owner Nov 19, 2019 Buy $2.79 2,544 7,098 1,861,924 Nov 26, 2019, 05:17 PM
Washer Susan B. President and CEO Sep 18, 2019 Option Exercise $3.50 5,700 19,950 28,408 Sep 20, 2019, 04:22 PM
Feinsod Matthew Interim Chief Medical Officer Jul 11, 2019 Option Exercise $3.75 592 2,220 56,052 Jul 15, 2019, 04:45 PM
Feinsod Matthew Interim Chief Medical Officer Jun 11, 2019 Option Exercise $3.70 685 2,535 54,644 Jun 20, 2019, 04:39 PM
Feinsod Matthew Interim Chief Medical Officer Jun 11, 2019 Option Exercise $3.77 685 2,582 54,644 Jun 13, 2019, 07:21 PM
Koenig Scott Director May 28, 2019 Option Exercise $0.35 32,018 11,206 34,246 May 30, 2019, 04:04 PM
Feinsod Matthew Interim Chief Medical Officer May 13, 2019 Option Exercise $4.06 685 2,781 53,329 May 20, 2019, 04:02 PM
Feinsod Matthew Interim Chief Medical Officer May 13, 2019 Option Exercise $4.20 685 2,877 53,329 May 15, 2019, 04:21 PM
Feinsod Matthew Interim Chief Medical Officer Apr 11, 2019 Option Exercise $4.61 606 2,794 52,014 Apr 15, 2019, 05:42 PM
Feinsod Matthew Interim Chief Medical Officer Mar 11, 2019 Option Exercise $3.97 667 2,648 50,620 Mar 13, 2019, 05:16 PM
Feinsod Matthew Interim Chief Medical Officer Feb 11, 2019 Option Exercise $3.29 791 2,602 49,287 Feb 13, 2019, 06:30 PM
Feinsod Matthew Interim Chief Medical Officer Jan 11, 2019 Option Exercise $3.20 713 2,282 48,078 Jan 15, 2019, 07:58 PM
Rosen James Director Dec 14, 2018 Buy $3.38 1,000 3,381 1,000 Dec 18, 2018, 08:29 PM
Aliski William Director Dec 14, 2018 Buy $3.25 6,000 19,477 8,500 Dec 18, 2018, 08:20 PM
Sullivan William A. Chief Financial Officer Dec 14, 2018 Buy $3.33 3,000 9,990 3,000 Dec 18, 2018, 08:10 PM
Shearman Mark S Chief Scientific Officer Dec 14, 2018 Sale $3.35 3,000 10,053 0 Dec 18, 2018, 07:58 PM
Washer Susan B. President and CEO Dec 14, 2018 Buy $3.34 2,380 7,949 22,708 Dec 18, 2018, 07:36 PM
Feinsod Matthew Interim Chief Medical Officer Dec 11, 2018 Option Exercise $6.11 611 3,733 46,791 Dec 13, 2018, 09:23 PM
Feinsod Matthew Interim Chief Medical Officer Nov 12, 2018 Option Exercise $7.05 685 4,829 45,402 Nov 14, 2018, 04:43 PM
Feinsod Matthew Interim Chief Medical Officer Oct 11, 2018 Option Exercise $6.46 612 3,954 44,087 Oct 15, 2018, 07:01 PM
Feinsod Matthew Interim Chief Medical Officer Sep 11, 2018 Option Exercise $3.92 685 2,689 42,699 Sep 13, 2018, 05:04 PM
Feinsod Matthew Interim Chief Medical Officer Aug 13, 2018 Option Exercise $4.00 592 2,368 41,384 Aug 15, 2018, 07:07 PM
Feinsod Matthew Interim Chief Medical Officer Jul 11, 2018 Option Exercise $4.15 685 2,843 39,976 Jul 13, 2018, 05:57 PM
Feinsod Matthew Interim Chief Medical Officer Jun 11, 2018 Option Exercise $4.55 606 2,757 38,661 Jun 13, 2018, 07:33 PM
Feinsod Matthew Interim Chief Medical Officer May 16, 2018 Option Exercise $5.60 3,425 19,180 37,267 May 18, 2018, 06:17 PM
Feinsod Matthew Interim Chief Medical Officer May 11, 2018 Option Exercise $4.90 685 3,357 40,692 May 15, 2018, 04:34 PM
Feinsod Matthew Interim Chief Medical Officer Apr 11, 2018 Option Exercise $4.00 685 2,740 39,377 Apr 13, 2018, 04:20 PM
Feinsod Matthew Interim Chief Medical Officer Feb 09, 2018 Option Exercise $3.95 733 2,895 26,729 Apr 06, 2018, 08:45 PM
Feinsod Matthew Interim Chief Medical Officer Jan 11, 2018 Option Exercise $4.30 791 3,401 25,462 Apr 06, 2018, 08:26 PM
Feinsod Matthew Interim Chief Medical Officer Dec 11, 2017 Option Exercise $3.75 3,395 12,731 24,253 Apr 06, 2018, 08:15 PM
Feinsod Matthew Interim Chief Medical Officer Mar 12, 2018 Option Exercise $4.30 667 2,868 32,126 Mar 14, 2018, 07:49 PM
Feinsod Matthew Interim Chief Medical Officer Jan 11, 2018 Option Exercise $4.30 855 3,677 28,793 Jan 16, 2018, 08:29 PM
Magovcevic Ivana Director Nov 16, 2016 Buy $9.63 3,000 28,875 3,000 Nov 17, 2016, 04:53 PM
Chulay Jeffrey D. VP and Chief Medical Officer Nov 01, 2016 Sale $7.05 1,000 7,051 20,400 Nov 02, 2016, 06:42 PM
Chulay Jeffrey D. VP and Chief Medical Officer Oct 19, 2016 Option Exercise $0.35 10,000 3,500 21,400 Oct 27, 2016, 08:24 PM
Chulay Jeffrey D. VP and Chief Medical Officer Oct 19, 2016 Option Exercise $0.35 1,000 350 12,400 Oct 21, 2016, 06:03 PM
Potter Stephen W See Remarks Sep 20, 2016 Buy $8.69 400 3,476 1,400 Sep 27, 2016, 05:12 PM
Potter Stephen W See Remarks Sep 16, 2016 Buy $8.97 1,000 8,970 1,000 Sep 27, 2016, 05:12 PM
Shearman Mark S Chief Scientific Officer Sep 22, 2016 Buy $8.87 3,000 26,601 3,000 Sep 26, 2016, 05:20 PM
BULLOCK LAWRENCE E Chief Financial Officer Sep 19, 2016 Buy $8.75 10,000 87,500 10,000 Sep 20, 2016, 04:51 PM
Washer Susan B. See Remarks Aug 29, 2016 Option Exercise $3.50 5,328 18,648 20,328 Aug 30, 2016, 05:43 PM
Chulay Jeffrey D. VP and Chief Medical Officer May 25, 2016 Option Exercise $3.50 2,000 7,000 11,900 May 26, 2016, 07:03 PM
Chulay Jeffrey D. VP and Chief Medical Officer May 11, 2016 Option Exercise $3.50 4,000 14,000 9,900 May 26, 2016, 07:00 PM
GLAXOSMITHKLINE PLC Former 10% Owner Feb 23, 2015 Sale $22.00 503,150 11,069,602 1,436,448 Feb 24, 2015, 04:05 PM
GLAXOSMITHKLINE PLC 10% Owner Dec 11, 2014 Sale $21.28 12,500 266,035 1,967,098 Feb 12, 2015, 06:31 PM
GLAXOSMITHKLINE PLC 10% Owner Dec 10, 2014 Sale $21.18 10,000 211,760 1,979,598 Feb 12, 2015, 06:31 PM
GLAXOSMITHKLINE PLC 10% Owner Dec 18, 2014 Sale $21.01 12,000 252,136 1,939,598 Feb 12, 2015, 06:31 PM
GLAXOSMITHKLINE PLC 10% Owner Dec 17, 2014 Sale $21.00 8,000 168,000 1,951,598 Feb 12, 2015, 06:31 PM
GLAXOSMITHKLINE PLC 10% Owner Dec 12, 2014 Sale $21.24 7,500 159,294 1,959,598 Feb 12, 2015, 06:31 PM
Menichella Daniel L V.P. & Chief Business Officer Jan 23, 2015 Option Exercise $4.90 1,996 9,780 1,996 Jan 26, 2015, 06:04 PM
Menichella Daniel L V.P. & Chief Business Officer Jan 23, 2015 Sale $24.90 1,996 49,700 0 Jan 26, 2015, 06:04 PM
Menichella Daniel L V.P. & Chief Business Officer Dec 22, 2014 Option Exercise $4.90 9,000 44,100 9,000 Dec 23, 2014, 02:54 PM
Menichella Daniel L V.P. & Chief Business Officer Dec 22, 2014 Sale $20.83 9,000 187,470 0 Dec 23, 2014, 02:54 PM
GLAXOSMITHKLINE PLC 10% Owner Apr 01, 2014 Buy $12.00 103,762 1,245,144 1,989,598 Apr 02, 2014, 12:42 PM
Wu Samuel Director Apr 01, 2014 Buy $12.00 75,735 908,820 1,452,196 Apr 01, 2014, 04:31 PM
Rosen James Director Apr 01, 2014 Buy $12.00 62,871 754,452 1,205,537 Apr 01, 2014, 04:31 PM
ORONSKY ARNOLD L Director Apr 01, 2014 Buy $12.00 75,736 908,832 1,452,216 Apr 01, 2014, 04:30 PM
MedImmune Ventures, Inc. 10% Owner Apr 01, 2014 Buy $12.00 75,735 908,820 1,452,196 Apr 01, 2014, 04:29 PM
Carroll Jill Director Apr 01, 2014 Buy $12.00 103,762 1,245,144 1,989,598 Apr 01, 2014, 04:29 PM
Alta Partners VIII, L.P. 10% Owner Apr 01, 2014 Buy $12.00 155,645 1,867,740 2,984,400 Apr 01, 2014, 04:28 PM
INTERWEST PARTNERS VIII LP 10% Owner Apr 01, 2014 Buy $12.00 75,376 904,512 1,452,216 Apr 01, 2014, 02:06 PM

Desktop Version

Owner Relationship Date Transaction Value($)
Potter Stephen W VP and Chief Business Officer Aug 15, 2020 Option Exercise 33,022
Shearman Mark S Chief Scientific Officer Aug 15, 2020 Option Exercise 33,022
Krol Patrick Johan Hendrik 10% Owner Dec 26, 2019 Sale 425,289
Krol Patrick Johan Hendrik 10% Owner Nov 19, 2019 Buy 7,098
Washer Susan B. President and CEO Sep 18, 2019 Option Exercise 19,950
Feinsod Matthew Interim Chief Medical Officer Jul 11, 2019 Option Exercise 2,220
Feinsod Matthew Interim Chief Medical Officer Jun 11, 2019 Option Exercise 2,535
Feinsod Matthew Interim Chief Medical Officer Jun 11, 2019 Option Exercise 2,582
Koenig Scott Director May 28, 2019 Option Exercise 11,206
Feinsod Matthew Interim Chief Medical Officer May 13, 2019 Option Exercise 2,781
Feinsod Matthew Interim Chief Medical Officer May 13, 2019 Option Exercise 2,877
Feinsod Matthew Interim Chief Medical Officer Apr 11, 2019 Option Exercise 2,794
Feinsod Matthew Interim Chief Medical Officer Mar 11, 2019 Option Exercise 2,648
Feinsod Matthew Interim Chief Medical Officer Feb 11, 2019 Option Exercise 2,602
Feinsod Matthew Interim Chief Medical Officer Jan 11, 2019 Option Exercise 2,282
Rosen James Director Dec 14, 2018 Buy 3,381
Aliski William Director Dec 14, 2018 Buy 19,477
Sullivan William A. Chief Financial Officer Dec 14, 2018 Buy 9,990
Shearman Mark S Chief Scientific Officer Dec 14, 2018 Sale 10,053
Washer Susan B. President and CEO Dec 14, 2018 Buy 7,949
Feinsod Matthew Interim Chief Medical Officer Dec 11, 2018 Option Exercise 3,733
Feinsod Matthew Interim Chief Medical Officer Nov 12, 2018 Option Exercise 4,829
Feinsod Matthew Interim Chief Medical Officer Oct 11, 2018 Option Exercise 3,954
Feinsod Matthew Interim Chief Medical Officer Sep 11, 2018 Option Exercise 2,689
Feinsod Matthew Interim Chief Medical Officer Aug 13, 2018 Option Exercise 2,368
Feinsod Matthew Interim Chief Medical Officer Jul 11, 2018 Option Exercise 2,843
Feinsod Matthew Interim Chief Medical Officer Jun 11, 2018 Option Exercise 2,757
Feinsod Matthew Interim Chief Medical Officer May 16, 2018 Option Exercise 19,180
Feinsod Matthew Interim Chief Medical Officer May 11, 2018 Option Exercise 3,357
Feinsod Matthew Interim Chief Medical Officer Apr 11, 2018 Option Exercise 2,740
Feinsod Matthew Interim Chief Medical Officer Feb 09, 2018 Option Exercise 2,895
Feinsod Matthew Interim Chief Medical Officer Jan 11, 2018 Option Exercise 3,401
Feinsod Matthew Interim Chief Medical Officer Dec 11, 2017 Option Exercise 12,731
Feinsod Matthew Interim Chief Medical Officer Mar 12, 2018 Option Exercise 2,868
Feinsod Matthew Interim Chief Medical Officer Jan 11, 2018 Option Exercise 3,677
Magovcevic Ivana Director Nov 16, 2016 Buy 28,875
Chulay Jeffrey D. VP and Chief Medical Officer Nov 01, 2016 Sale 7,051
Chulay Jeffrey D. VP and Chief Medical Officer Oct 19, 2016 Option Exercise 3,500
Chulay Jeffrey D. VP and Chief Medical Officer Oct 19, 2016 Option Exercise 350
Potter Stephen W See Remarks Sep 20, 2016 Buy 3,476
Potter Stephen W See Remarks Sep 16, 2016 Buy 8,970
Shearman Mark S Chief Scientific Officer Sep 22, 2016 Buy 26,601
BULLOCK LAWRENCE E Chief Financial Officer Sep 19, 2016 Buy 87,500
Washer Susan B. See Remarks Aug 29, 2016 Option Exercise 18,648
Chulay Jeffrey D. VP and Chief Medical Officer May 25, 2016 Option Exercise 7,000
Chulay Jeffrey D. VP and Chief Medical Officer May 11, 2016 Option Exercise 14,000
GLAXOSMITHKLINE PLC Former 10% Owner Feb 23, 2015 Sale 11,069,602
GLAXOSMITHKLINE PLC 10% Owner Dec 11, 2014 Sale 266,035
GLAXOSMITHKLINE PLC 10% Owner Dec 10, 2014 Sale 211,760
GLAXOSMITHKLINE PLC 10% Owner Dec 18, 2014 Sale 252,136
GLAXOSMITHKLINE PLC 10% Owner Dec 17, 2014 Sale 168,000
GLAXOSMITHKLINE PLC 10% Owner Dec 12, 2014 Sale 159,294
Menichella Daniel L V.P. & Chief Business Officer Jan 23, 2015 Option Exercise 9,780
Menichella Daniel L V.P. & Chief Business Officer Jan 23, 2015 Sale 49,700
Menichella Daniel L V.P. & Chief Business Officer Dec 22, 2014 Option Exercise 44,100
Menichella Daniel L V.P. & Chief Business Officer Dec 22, 2014 Sale 187,470
GLAXOSMITHKLINE PLC 10% Owner Apr 01, 2014 Buy 1,245,144
Wu Samuel Director Apr 01, 2014 Buy 908,820
Rosen James Director Apr 01, 2014 Buy 754,452
ORONSKY ARNOLD L Director Apr 01, 2014 Buy 908,832
MedImmune Ventures, Inc. 10% Owner Apr 01, 2014 Buy 908,820
Carroll Jill Director Apr 01, 2014 Buy 1,245,144
Alta Partners VIII, L.P. 10% Owner Apr 01, 2014 Buy 1,867,740
INTERWEST PARTNERS VIII LP 10% Owner Apr 01, 2014 Buy 904,512